BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19128788)

  • 1. Hematopoietic stem cell quiescence: yet another role for p53.
    van Os R; de Haan G; Dykstra BJ
    Cell Stem Cell; 2009 Jan; 4(1):7-8. PubMed ID: 19128788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 regulates hematopoietic stem cell quiescence.
    Liu Y; Elf SE; Miyata Y; Sashida G; Liu Y; Huang G; Di Giandomenico S; Lee JM; Deblasio A; Menendez S; Antipin J; Reva B; Koff A; Nimer SD
    Cell Stem Cell; 2009 Jan; 4(1):37-48. PubMed ID: 19128791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.
    Asai T; Liu Y; Di Giandomenico S; Bae N; Ndiaye-Lobry D; Deblasio A; Menendez S; Antipin Y; Reva B; Wevrick R; Nimer SD
    Blood; 2012 Aug; 120(8):1601-12. PubMed ID: 22776820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells.
    Yamashita M; Nitta E; Nagamatsu G; Ikushima YM; Hosokawa K; Arai F; Suda T
    Biochem Biophys Res Commun; 2013 Nov; 441(1):196-201. PubMed ID: 24140061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating quiescence: new insights into hematopoietic stem cell biology.
    Passegué E; Wagers AJ
    Dev Cell; 2006 Apr; 10(4):415-7. PubMed ID: 16580989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.
    Insinga A; Cicalese A; Faretta M; Gallo B; Albano L; Ronzoni S; Furia L; Viale A; Pelicci PG
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3931-6. PubMed ID: 23417300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior.
    Liu Y; Elf SE; Asai T; Miyata Y; Liu Y; Sashida G; Huang G; Di Giandomenico S; Koff A; Nimer SD
    Cell Cycle; 2009 Oct; 8(19):3120-4. PubMed ID: 19755852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells.
    Lacorazza HD; Yamada T; Liu Y; Miyata Y; Sivina M; Nunes J; Nimer SD
    Cancer Cell; 2006 Mar; 9(3):175-87. PubMed ID: 16530702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of BRCA1 disturbs hematopoietic stem and progenitor cells quiescence and function.
    Bai L; Shi G; Zhang X; Dong W; Zhang L
    Exp Cell Res; 2013 Oct; 319(17):2739-46. PubMed ID: 23850973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
    Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
    Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells.
    Meng A; Wang Y; Van Zant G; Zhou D
    Cancer Res; 2003 Sep; 63(17):5414-9. PubMed ID: 14500376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
    Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
    DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDB1 is essential for genomic stability in developing epidermis.
    Cang Y; Zhang J; Nicholas SA; Kim AL; Zhou P; Goff SP
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2733-7. PubMed ID: 17301228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.